Skip to Content

M 030 (Nifedipine extended-release 30 mg)

Pill imprint M 030 has been identified as Nifedipine extended-release 30 mg.

Nifedipine is used in the treatment of high blood pressure; raynaud's syndrome; hypertensive emergency; angina pectoris prophylaxis; heart failure (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nifedipine 30 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Nifedipine extended-release 30 mg M 030
Nifedipine extended-release 30 mg M 030
Nifedipine extended-release
M 030
30 mg
Prescription only
Drug Class:
Calcium channel blocking agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
ferrosoferric oxide
ferric oxide red
hydroxypropyl cellulose
magnesium stearate
polyethylene glycol
polyvinyl alcohol
propylene glycol
sodium chloride
magnesium silicate
titanium dioxide
ferric oxide yellow
cellulose acetate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0400 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.